Topic: pharma

When Kristen Williams got a call from a former colleague about taking on the in-house legal work for Pacira, she knew generally what to expect if she got back into the biotech biome. The two had worked together before, at a biotech bought out by a larger drugmaker

At 21, Genentech’s Nancy Valente had never really thought seriously about a career in medicine. Then her father passed away from pancreatic cancer. That loss marked a “critical influence” for Valente in her career path. “I wanted to be able to make a difference for patients who have very serious illness, like his cancer,” she says.